NEW YORK (GenomeWeb) – Sera Prognostics said today that it has increased its Series B financing round with a $5 million investment by the Bill & Melinda Gates Foundation.

The investment brings total funding in the round to $25 million. Sera originally announced the closing of the round last month.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.